Purification of natural killer-like Kurloff cells and arachidonic acid metabolism.
Pulmonary and splenic Kurloff cells have been purified from estrogen-treated guinea pig. Enzymatic digestion of lung tissue and mechanical dispersion of cells yielded about 650 x 10(6) viable cells. After centrifugal elutriation and centrifugation on continuous Percoll gradient, a population of high-density (1,100 g/ml) pulmonary Kurloff cells were obtained with high viability (approximately 99%) and purity (approximately 99%). Splenic Kurloff cells have been isolated by disruption of spleen tissue and centrifugation on continuous Percoll gradient. High-density splenic Kurloff cells (150 x 10(6) cells per spleen) were also obtained with high purity (approximately 99%) and viability (approximately 99%). Pulmonary and splenic Kurloff cells were incubated with various concentrations of arachidonic acid (10, 30 and 100 microM) in the absence or presence of 2 microM ionophore A23187. With 10 microM arachidonic acid the relative production of cyclooxygenase products was the following: TxB2 greater than PGE2 approximately PGI2. For an arachidonic acid concentration superior to 10 microM, the profile of release was PGE2 much greater than TxB2 greater than PGI2. Arachidonic acid metabolism through the 5-lipoxygenase pathway was also studied by incubating pulmonary or splenic Kurloff cells with 10 microM arachidonic acid in the absence or presence of 2 microM ionophore A23187, or in some experiments, with 2.5 microM leukotriene A4. Reverse phase HPLC profiles clearly indicated that high-density Kurloff cells did not express 5-lipoxygenase activity. However, these cells showed the ability to convert exogenous leukotriene A4 into leukotriene B4 suggesting the presence of LTA4 hydrolase activity. These data have been confirmed by a sensitive RIA method. This study constitutes the first report on the purification of pulmonary Kurloff cells and on arachidonic acid metabolism by these cells. The possible implications of Kurloff cells in various biological events are discussed.
Maghni
K
K
Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, P.Q., Canada.
Robidoux
C
C
Laporte
J
J
Hallee
A
A
Borgeat
P
P
Sirois
P
P
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D019746:Intramolecular Oxidoreductases; D007535:Isomerases / Q000032:analysis*; D007694:Killer Cells, Natural / Q000378:metabolism*; D008168:Lung / Q000166:cytology; D000071876:Prostaglandin-E Synthases; D013154:Spleen / Q000166:cytology
D016718:Arachidonic Acid; D004958:Estradiol; D007535:Isomerases; D019746:Intramolecular Oxidoreductases; D000071876:Prostaglandin-E Synthases